Elevated second-trimester dimeric inhibin A levels identify Down syndrome pregnancies

This publication has 17 references indexed in Scilit:

• Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A
  Clinical Endocrinology, 1996
• Evaluation of maternal serum dimeric inhibin a as a first‐trimester marker of down's syndrome
  Prenatal Diagnosis, 1995
• Maternal serum dimeric inhibin A in second‐trimester Down's syndrome pregnancies
  Prenatal Diagnosis, 1995
• Detection of dimeric inhibin throughout the human menstrual cycle by two‐site enzyme immunoassay
  Clinical Endocrinology, 1994
• Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for Screening
  New England Journal of Medicine, 1994
• Immunoassays for inhibin and its subunits Further applications of the synthetic peptide approach
  Journal of Immunological Methods, 1993
• Prenatal Screening for Down's Syndrome with Use of Maternal Serum Markers
  New England Journal of Medicine, 1992
• Combining maternal serum α-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35
  American Journal of Obstetrics and Gynecology, 1989
• Screening for Fetal Down's Syndrome in Pregnancy by Measuring Maternal Serum Alpha-Fetoprotein Levels
  New England Journal of Medicine, 1987
• Risks of midtrimester amniocentesis; assessment in 3000 pregnancies
  BJOG: An International Journal of Obstetrics and Gynaecology, 1985